US EditionCBO finds health agency cuts would result in fewer new drugs
UNITED STATES, JUL 18 – A 10 percent NIH budget cut and FDA staffing reductions could delay drug approvals, preventing up to 53 new drugs from reaching the market in 30 years, the CBO found.
Summary by Roll Call
3 Articles
3 Articles
CBO finds health agency cuts would result in fewer new drugs
The Trump administration’s proposed cuts at the National Institutes of Health and Food and Drug Administration could lower the number of new drugs that come to market in the next three decades, according to an analysis released Friday by the Congressional Budget Office. Under hypothetical scenarios of a permanent 10 percent budget cut to the NIH and a nine-month drug review delay at the FDA due to staffing cuts, an estimated 53 drugs would not c…
·Washington, United States
Read Full Article
Trump's budget proposal's cuts to the National Institutes of Health would result in fewer drugs coming to market in the long run, according to the Congressional Budget Office.
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
